Forty years have passed since the landmark publication on the importance of Helicobacter pylori as a triggering factor for gastritis by Warren and Marshall. In that time, the understanding of associations between H. pylori infection of the gastric mucosa with both inflammatory and malignant diseases of the stomach and extragastric diseases has grown steadily. In 2022, the fourth version of the S2k guideline “Helicobacter pylori and gastroduodenal ulcer disease” of the German Society for Digestive and Metabolic Diseases was published. The most relevant innovations are summarized here briefly, concisely and clinically applicable.
Autoren
- PD Dr. med. Kerstin Schütte
- PD Dr. med. Christian Schulz
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Lymphoma
Treatment goal: slow progression, improve quality of life
- PancNEN, PancNET & PancNEC
Neuroendocrine tumors of the pancreas
- Heart failure
Interventional treatment of the tricuspid valve
- Lipoprotein(a)
Current and future treatment options
- Lichen sclerosus
Topical corticosteroids still the first choice
- Breast Cancer
On the trail of triple-negative breast cancer
- Headache treatment
The therapy of migraine
- Sleep disorders in old age